Sequential Compression Devices (SCDs) do more than apply pressure. They deliver a therapy pattern a patient can literally feel, cycle after cycle. When that pattern is smooth and consistent, it supports circulation therapy while maintaining comfort. When it is not, even small variations can make compression feel abrupt, uneven, or unpredictable.
That is why SCD design is as much about controlled motion as it is about pressure targets. The MD3100 application study frames the core challenge clearly: SCDs rely on precisely timed pneumatic inflation and release to create a repeatable compression sequence, not a single static pressure event.
Modern SCD therapy profiles are increasingly refined. Instead of a hard on/off squeeze, many systems aim for a gradual ramp up, a controlled peak, then a clean release before the next chamber inflates. Done well, that sequencing helps create a consistent therapy rhythm and a more comfortable patient experience.
The problem is that inconsistency shows up fast. The study calls out what designers often see when inflation control is not precise: abrupt pressure changes, uneven ramping, and cycle-to-cycle variation. Over time, that can affect both comfort and confidence in the therapy.
The engineering constraint: compact modules, low flow, continuous use
SCD control modules are small, typically operate at low flow rates, and may run continuously. That puts pressure on the pneumatic subsystem to be responsive without becoming complicated or air-hungry.
For OEM teams, the requirement is not simply “inflate and deflate.” It is:
• Prevent overshoot and harsh transitions
• Keep air consumption and complexity under control
• Avoid delays that disrupt the intended therapy rhythm
• Translate timing commands into pneumatic motion immediately
This is where the control method matters as much as the pneumatic hardware.
Where the MD3100 fits in the SCD control stack
The MD3100 Analog Electronic Regulator is positioned in the application study as a way to deliver smooth, electrically commanded inflation inside an SCD platform. Rather than stepping between states, it converts an analog control signal directly into proportional pneumatic output, giving the system a cleaner way to shape each compression cycle.
A key point in the study is response. The MD3100 is described as responding immediately to therapy timing commands, supporting gradual inflation, consistent peak compression, and clean release between cycles.
It also highlights why analog control still matters in applications like this: the MD3100’s analog architecture avoids digital processing delays that can introduce timing lag and disrupt the intended rhythm of the squeeze.
The study further notes built-in output monitoring, providing real-time feedback to help maintain consistent operation across repeated therapy sessions.
Why this matters as SCDs evolve
SCDs are moving toward quieter operation, more compact designs, and more tailored therapy profiles. As that happens, the demand grows for predictable pneumatic motion that does not add variability or unnecessary design complexity.
The takeaway for manufacturers is straightforward: if therapy quality depends on timing you can feel, then the inflation control element has to behave consistently over long use cycles.
Marsh Medical can help you evaluate how the MD3100 fits into your SCD platform’s therapy profile, control architecture, and reliability goals.
